Allogeneic tumor-specific cytotoxic T lymphocytes
β Scribed by Joan M. Redd; Anne-Catherine Lagarde; Carol A. Kruse; Donald Bellgrau
- Publisher
- Springer-Verlag
- Year
- 1992
- Tongue
- English
- Weight
- 803 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0340-7004
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The major histocompatibility complex class Iβrestricted CD8^+^ cytotoxic Tβlymphocyte (CTL) effector arm of the adaptive immune response can specifically recognize and destroy tumor cells expressing peptide antigens. Although adoptive Tβcell therapy has been successfully used for the tr
## Abstract Donorβderived cytotoxic T lymphocytes (CTL) that respond to tumor antigens emerge after hematopoietic stem cell transplantation (HSCT), particularly in association with the status of immune recovery. To analyze the frequency of CTL against PR1, PRAME and WT1 after HSCT, a tetramerβbased